Evidence map›Paper›PMID 18083900›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2008

Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.

Chunyu Zeng, Ines Armando, Yingjin Luo, Gilbert M Eisner, Robin A Felder, Pedro A Jose

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 85 citations in OpenAlex.

  1. Cardiovascular pharmacology of dopaminergic agents in humans: a review.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026
    Review
  2. Review
  3. Article
  4. Dopamine DHypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  5. Effect of DCardiology discovery · 2023
    Article
  6. Review
  7. Synergistic Effect of Uroguanylin and DJournal of the American Heart Association · 2022
    Article
  8. Review
  9. Dopamine DPflugers Archiv : European journal of physiology · 2020
    Article
  10. New roles for dopamine DMolecular psychiatry · 2020
    Article
  11. Dopamine DScientific reports · 2019
    Article
  12. Review
  13. Review
  14. Activation of angiotensin II type 1 receptors increases DHypertension research : official journal of the Japanese Society of Hypertension · 2017
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chunyu ZengDepartment of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing City 400042, People's Republic of China. cyzeng1@hotmail.com
Ines Armando
Yingjin Luo
Gilbert M Eisner
Robin A Felder
Pedro A Jose
Army Medical University · CN

Funding

Renal Vascular Oxidative Stress in HypertensionP01HL068686 · NHLBI · GEORGETOWN UNIVERSITY · PI JOSE, PEDRO A., SANDBERG, KATHRYN L · 2001 to 2017
$28.8M
RENAL DOPAMINE-1 RECEPTOR DEFECT IN HYPERTENSIONR01DK039308 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI JOSE, PEDRO A. · 1987 to 2020
$7.4M
STRUCTURAL AND FUNCTIONAL DEVELOPMENT OF THE KIDNEYP50DK052612 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GOMEZ, ROBERTO ARIEL · 1997 to 2006
$6.8M
VASOACTIVE HORMONES: RECEPTORS AND SIGNALING MECHANISMSP01HL041618 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI HOPFER, ULRICH · 1989 to 2004
$6.7M
Renal Dopamine Receptor & RegulationR37HL023081 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI JOSE, PEDRO A. · 2007 to 2016
$4.3M
RENAL DOPAMINE RECEPTOR REGULATION AND FUNCTIONR01HL023081 · NHLBI · GEORGETOWN UNIVERSITY · PI JOSE, PEDRO A. · 1985 to 2006
$2.4M
NHLBI NIH HHS HL-23081NHLBI NIH HHS HL-41618NHLBI NIH HHS HL-68686NHLBI NIH HHS P01 HL041618NHLBI NIH HHS P01 HL068686NHLBI NIH HHS R01 HL023081NHLBI NIH HHS R37 HL023081NIDDK NIH HHS DK-39308NIDDK NIH HHS DK-52612NIDDK NIH HHS P50 DK052612NIDDK NIH HHS R01 DK039308
6 · The paper itself

Abstract

Dopamine plays an important role in the pathogenesis of hypertension by regulating epithelial sodium transport and by interacting with vasoactive hormones/humoral factors, such as aldosterone, angiotensin, catecholamines, endothelin, oxytocin, prolactin pro-opiomelancortin, reactive oxygen species, renin, and vasopressin. Dopamine receptors are classified into D(1)-like (D(1) and D(5)) and D(2)-like (D(2), D(3), and D(4)) subtypes based on their structure and pharmacology. In recent years, mice deficient in one or more of the five dopamine receptor subtypes have been generated, leading to a better understanding of the physiological role of each of the dopamine receptor subtypes. This review summarizes the results from studies of various dopamine receptor mutant mice on the role of individual dopamine receptor subtypes and their interactions with other G protein-coupled receptors in the regulation of blood pressure.

Indexed as

AnimalsBlood PressureDopamineHypertensionMiceMice, KnockoutReceptors, DopamineReceptors, Dopamine D1Receptors, Dopamine D2Receptors, Dopamine D3Receptors, Dopamine D4Receptors, Dopamine D5DopamineReceptors, DopamineReceptors, Dopamine D1Receptors, Dopamine D2Receptors, Dopamine D3Receptors, Dopamine D4Receptors, Dopamine D5

Identifiers

PMID18083900
PMCPMC4029502
OpenAlexW2000165288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.